Celeste Ferber is Secretary & SVP at ADURO BIOTECH, INC. (ADRO). They have made 4 open-market trades across 1 company since 2019, most recently 2020-09-15.
CIK 0001767181
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ADRO | 38,687 | $565K |
Shares reported on the most recent Form 4, priced at the 2020-09-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADRO | SELL | 2020-09-15 | 2020-09-17 | $2.39 | $6K | -9.1% | N/A | N/A |
| ADRO | SELL | 2020-08-07 | 2020-08-11 | $2.55 | $20K | +20.6% | -6.5% | N/A |
| ADRO | SELL | 2019-12-12 | 2019-12-16 | $1.16 | $473 | +6.3% | +10.7% | +104.5% |
| ADRO | SELL | 2019-09-13 | 2019-09-17 | $1.31 | $3K | -21.1% | -18.8% | -16.5% |
| ADRO | SELL · 10b5-1 | 2019-05-20 | 2019-05-22 | $3.21 | $6K | -40.7% | -42.6% | -58.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.